Literature DB >> 3943743

Abnormal blood rheology in retinal vein occlusion. A preliminary report.

M Peduzzi, A Debbia, F Guerrieri, R Bolzani.   

Abstract

Hemorheological factors were studied in 34 patients affected by retinal vein occlusion (RVO) and in 25 control subjects. Whole blood viscosity, plasma viscosity, fibrinogen and hematocrit were increased in RVO patients compared with controls. Whole-blood filterability was reduced in RVO patients compared with controls. However, when evaluating the type of capillaropathy at fluorescein angiography, blood viscosity and plasma viscosity were altered in both patients with and without evidence of capillary nonperfusion. Reduction of blood filterability showed statistical significance only in patients with capillary nonperfusion. This finding suggests that reduced whole-blood filterability might be a causal factor in the development of capillary nonperfusion in RVO patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943743     DOI: 10.1007/bf02144143

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  11 in total

1.  A simple method for measuring erythrocyte deformability.

Authors:  H L Reid; A J Barnes; P J Lock; J A Dormandy; T L Dormandy
Journal:  J Clin Pathol       Date:  1976-09       Impact factor: 3.411

2.  Coagulation and fibrinolytic studies in 23 patients with occlusion of the retinal vessels.

Authors:  M Pandolfi; S Isacson; B Astedt
Journal:  Acta Ophthalmol (Copenh)       Date:  1972

3.  Abnormal blood viscosity and erythrocyte deformability in retinal vein occlusion.

Authors:  M Peduzzi; L Codeluppi; M Poggi; P Baraldi
Journal:  Am J Ophthalmol       Date:  1983-09       Impact factor: 5.258

4.  Haemostatic studies on retinal vein occlusion. Fibrinolytic response to venostasis as a prognostic factor for spontaneous recanalization.

Authors:  M Peduzzi; V De Rosa; S Fonda; S Coccheri
Journal:  Thromb Res       Date:  1981 Oct 1-15       Impact factor: 3.944

5.  Systemic factors contributory to retinal vein occlusion.

Authors:  M A McGrath; F Wechsler; A B Hunyor; R Penny
Journal:  Arch Intern Med       Date:  1978-02

6.  Viscosity and retinal vein thrombosis.

Authors:  C P Ring; T C Pearson; M D Sanders; G Wetherley-Mein
Journal:  Br J Ophthalmol       Date:  1976-06       Impact factor: 4.638

7.  Red-cell aggregation and red-cell deformability in diabetes.

Authors:  H Schmid-Schönbein; E Volger
Journal:  Diabetes       Date:  1976       Impact factor: 9.461

8.  [Blood viscosity and erythrocyte deformability in diabetic retinopathy].

Authors:  M Melli; M Poggi; L Codeluppi; P Baraldi; F Torlai; M Peduzzi
Journal:  Ric Clin Lab       Date:  1983

9.  Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion.

Authors:  G E Trope; G D Lowe; B M McArdle; J T Douglas; C D Forbes; C M Prentice; W S Foulds
Journal:  Br J Ophthalmol       Date:  1983-03       Impact factor: 4.638

10.  Alterations in blood elements in the pathogenesis of diabetic retinopathy.

Authors:  H L Little
Journal:  Ophthalmology       Date:  1981-07       Impact factor: 12.079

View more
  12 in total

1.  Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease.

Authors:  M Cahill; M Karabatzaki; R Meleady; H Refsum; P Ueland; D Shields; D Mooney; I Graham
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

Review 2.  Central retinal vein occlusion: what's the story?

Authors:  T H Williamson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

3.  In vivo cannulation of retinal vessels.

Authors:  B E Allf; E de Juan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

4.  Influence of age, systemic blood pressure, smoking, and blood viscosity on orbital blood velocities.

Authors:  T H Williamson; G D Lowe; G M Baxter
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

5.  The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; S E Moss; S M Meuer
Journal:  Trans Am Ophthalmol Soc       Date:  2000

6.  Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study.

Authors:  T H Williamson; A Rumley; G D Lowe
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

7.  Hemodilution therapy using automated erythrocytapheresis in central retinal vein occlusion: results of a multicenter randomized controlled study.

Authors:  Agnès Glacet-Bernard; Marielle Atassi; Christine Fardeau; Jean-Paul Romanet; Matthieu Tonini; John Conrath; Philippe Denis; Martine Mauget-Faÿsse; Gabriel Coscas; Gisèle Soubrane; Eric Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-10-17       Impact factor: 3.117

8.  Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion.

Authors:  H C Chen; J Wiek; A Gupta; A Luckie; E M Kohner
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

9.  Hemodilution therapy in central retinal vein occlusion. One-year results of a prospective randomized study.

Authors:  S Wolf; O Arend; B Bertram; A Remky; K Schulte; K J Wald; M Reim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-01       Impact factor: 3.117

10.  Protective effect of paraoxonase 1 gene variant L55M in retinal vein occlusion.

Authors:  Huseyin Ortak; Erkan Söğüt; Omer Ateş; Unal Erkorkmaz; Ismail Benli; Ali Akbas; Selim Demir; Hüseyin Ozyurt
Journal:  Mol Vis       Date:  2013-02-25       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.